PineTree Therapeutics
Cambridge
About PineTree Therapeutics
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $87.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: pinetreetx.com
Industries & Categories
Biotechnology, Medical, Oncology, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/pinetree-therapeutics-97180 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.